Erythropoietin Mediated Bone Loss in Mice Is Dose-Dependent and Mostly Irreversible

Recent studies have demonstrated that erythropoietin (EPO) treatment in mice results in trabecular bone loss. Here, we investigated the dose-response relationship between EPO, hemoglobin (Hgb) and bone loss and examined the reversibility of EPO-induced damage. Increasing doses of EPO over two weeks...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Sci
Main Authors: Kolomansky, Albert, Hiram-Bab, Sahar, Ben-Califa, Nathalie, Liron, Tamar, Deshet-Unger, Naamit, Mittelman, Moshe, Oster, Howard S., Rauner, Martina, Wielockx, Ben, Neumann, Drorit, Gabet, Yankel
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7312352/
https://ncbi.nlm.nih.gov/pubmed/32471308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21113817
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados